Profile data is unavailable for this security.
About the company
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
- Revenue in USD (TTM)2.72bn
- Net income in USD47.00m
- Incorporated2018
- Employees12.30k
- LocationEnvista Holdings Corp200 S. Kraemer Blvd., Bldg. EBREA 92821United StatesUSA
- Phone+1 (714) 817-5418
- Fax+1 (302) 655-5049
- Websitehttps://envistaco.com/en
More ▼
Mergers & acquisitions
| Acquired company | NVST:NYQ since announced | Transaction value |
|---|---|---|
| Alpha Bio France SAS | 52.30% | -- |
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DENTSPLY SIRONA Inc | 3.62bn | -882.00m | 2.74bn | 14.00k | -- | 1.85 | -- | 0.7549 | -4.43 | -4.43 | 18.18 | 7.41 | 0.5903 | 2.72 | 5.47 | 258,857.10 | -14.35 | -4.06 | -18.88 | -4.83 | 51.10 | 53.14 | -24.31 | -8.59 | 0.9865 | 9.68 | 0.6184 | -- | -4.34 | -1.17 | -589.39 | -- | 7.91 | 11.28 |
| Integer Holdings Corp | 1.83bn | 87.20m | 3.05bn | 11.00k | 36.37 | 1.75 | 14.46 | 1.67 | 2.40 | 2.39 | 51.76 | 49.83 | 0.5578 | 5.04 | 4.83 | 166,461.30 | 2.66 | 3.28 | 2.84 | 3.54 | 27.15 | 26.70 | 4.76 | 6.38 | 2.45 | 5.23 | 0.4112 | 0.00 | 10.35 | 6.41 | 35.80 | 5.82 | 16.99 | -- |
| LivaNova PLC | 1.35bn | -217.49m | 3.63bn | 2.90k | -- | 3.13 | -- | 2.69 | -4.01 | -4.01 | 24.64 | 21.19 | 0.5311 | 2.58 | 6.60 | 465,159.30 | -8.56 | -4.14 | -11.07 | -5.03 | 68.50 | 67.61 | -16.12 | -9.04 | 1.12 | 10.22 | 0.273 | -- | 8.66 | 2.94 | 260.39 | -- | 10.98 | -- |
| ICU Medical Inc | 2.32bn | -7.36m | 3.65bn | 15.00k | -- | 1.71 | 18.61 | 1.57 | -0.3109 | -0.3109 | 94.30 | 86.17 | 0.552 | 2.24 | 12.70 | 154,690.90 | -0.206 | -0.2042 | -0.2351 | -0.2306 | 36.47 | 33.82 | -0.3731 | -0.3326 | 1.19 | 1.62 | 0.3829 | -- | 5.44 | 13.47 | -296.86 | -- | -3.18 | -- |
| Lantheus Holdings Inc | 1.53bn | 167.68m | 4.46bn | 808.00 | 28.26 | 3.99 | 19.21 | 2.92 | 2.38 | 2.38 | 21.90 | 16.88 | 0.7055 | 8.67 | 4.48 | 1,888,531.00 | 7.75 | 9.87 | 10.50 | 11.33 | 62.23 | 60.44 | 10.99 | 12.86 | 2.49 | -- | 0.337 | 0.00 | 18.32 | 34.59 | -4.35 | 58.06 | 29.27 | -- |
| TransMedics Group Inc | 566.35m | 90.47m | 4.56bn | 728.00 | 56.00 | 12.81 | 39.24 | 8.04 | 2.38 | 2.41 | 14.48 | 10.40 | 0.6541 | 4.65 | 6.63 | 777,958.80 | 10.45 | -5.73 | 11.37 | -6.28 | 60.28 | 62.37 | 15.97 | -11.86 | 7.13 | 31.19 | 0.5903 | -- | 82.74 | 79.64 | 241.70 | -- | 279.42 | -- |
| Stevanato Group SpA | 1.39bn | 166.89m | 4.72bn | 5.52k | 25.51 | 2.50 | 17.75 | 3.40 | 0.6114 | 0.6114 | 5.09 | 6.25 | 0.5058 | 2.95 | 2.65 | 251,631.70 | 6.08 | 8.02 | 7.63 | 10.94 | 29.27 | 31.01 | 12.01 | 13.24 | 1.30 | 30.00 | 0.2386 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Teleflex Inc | 3.19bn | -327.85m | 4.73bn | 14.10k | -- | 1.24 | -- | 1.48 | -7.35 | -7.36 | 70.55 | 86.48 | 0.4154 | 2.05 | 6.00 | 226,240.30 | -4.27 | 4.58 | -4.69 | 5.01 | 53.67 | 54.77 | -10.28 | 11.38 | 1.53 | 6.78 | 0.4114 | 19.74 | 2.45 | 3.26 | -80.38 | -31.40 | 4.25 | 0.00 |
| Merit Medical Systems Inc | 1.48bn | 118.43m | 4.82bn | 7.40k | 41.61 | 3.15 | 19.70 | 3.26 | 1.95 | 1.95 | 24.37 | 25.80 | 0.5898 | 2.39 | 7.38 | 199,611.90 | 4.73 | 3.49 | 5.17 | 3.93 | 48.47 | 45.37 | 8.02 | 5.65 | 2.86 | 14.41 | 0.324 | 0.00 | 7.89 | 6.40 | 27.48 | 85.69 | -14.13 | -- |
| iRhythm Holdings, Inc | 702.57m | -51.46m | 4.90bn | 2.00k | -- | 40.19 | -- | 6.98 | -1.62 | -1.62 | 22.11 | 3.78 | 0.7377 | 12.04 | 9.15 | 351,286.50 | -5.40 | -20.12 | -6.21 | -24.37 | 70.35 | 68.61 | -7.32 | -23.90 | 4.50 | -- | 0.8418 | -- | 20.13 | 22.50 | 8.20 | -- | 19.06 | -- |
| Envista Holdings Corp | 2.72bn | 47.00m | 4.96bn | 12.30k | 110.10 | 1.60 | 30.41 | 1.82 | 0.2749 | 0.2749 | 16.10 | 18.96 | 0.4931 | 4.63 | 6.86 | -- | 0.8523 | -2.14 | 1.01 | -2.58 | 54.93 | 56.63 | 1.73 | -5.21 | 2.04 | 6.73 | 0.318 | -- | 8.32 | 7.11 | 104.20 | 2.03 | -1.03 | -- |
| Caris Life Sciences Inc | -100.00bn | -100.00bn | 6.07bn | -- | -- | 12.68 | -- | -- | -- | -- | -- | 1.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 9.36 | -- | 0.4404 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Glaukos Corp | 469.82m | -87.61m | 6.26bn | 995.00 | -- | 8.13 | -- | 13.33 | -1.55 | -1.55 | 8.28 | 13.41 | 0.4879 | 1.76 | 6.06 | 472,180.90 | -9.10 | -11.24 | -9.92 | -12.04 | 76.87 | 73.54 | -18.65 | -36.68 | 4.47 | -- | 0.0817 | -- | 21.85 | 10.10 | -8.70 | -- | 5.93 | -- |
| Bruker Corp | 3.44bn | -23.70m | 6.45bn | 11.40k | -- | 2.64 | 33.44 | 1.87 | -0.1562 | -0.1562 | 22.65 | 16.06 | 0.5481 | 1.44 | 5.23 | 301,763.80 | -0.3554 | 6.80 | -0.4523 | 9.20 | 48.00 | 50.00 | -0.6485 | 9.66 | 0.8877 | 9.34 | 0.4462 | 10.87 | 13.56 | 10.19 | -73.53 | -10.52 | 9.57 | 4.56 |
| Avantor Inc | 6.58bn | -82.20m | 6.57bn | 13.50k | -- | 1.18 | 20.19 | 0.9996 | -0.1203 | -0.1203 | 9.64 | 8.17 | 0.5364 | 5.58 | 6.07 | 487,051.80 | -0.6706 | 3.94 | -0.7693 | 4.48 | 33.13 | 33.76 | -1.25 | 6.87 | 0.9639 | 3.95 | 0.4092 | 0.00 | -2.64 | 2.35 | 121.58 | -- | 23.59 | -- |
Data as of Feb 12 2026. Currency figures normalised to Envista Holdings Corp's reporting currency: US Dollar USD
55.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 14.81m | 9.01% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 14.32m | 8.71% |
| Ariel Investments LLCas of 30 Sep 2025 | 12.00m | 7.30% |
| Dimensional Fund Advisors LPas of 30 Sep 2025 | 9.12m | 5.55% |
| Atlanta Capital Management Co. LLCas of 30 Sep 2025 | 8.67m | 5.27% |
| Franklin Mutual Advisers LLCas of 31 Dec 2025 | 7.99m | 4.86% |
| Harris Associates LPas of 30 Sep 2025 | 6.85m | 4.17% |
| Gates Capital Management, Inc.as of 30 Sep 2025 | 6.22m | 3.79% |
| AllianceBernstein LPas of 30 Sep 2025 | 6.10m | 3.71% |
| Victory Capital Management, Inc. (Investment Management)as of 30 Sep 2025 | 5.91m | 3.59% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
